{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:45:05Z","timestamp":1793393105798,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Receptor-interacting protein 1 (RIP1; RIPK1) is a key regulator of multiple signaling pathways that mediate inflammatory responses and cell death. TNF-TNFR1 triggered signaling complex formation, subsequent NF-\u03baB and MAPK activation and induction of cell death involve RIPK1 ubiquitination at several lysine residues including Lys376 and Lys115. Here we show that mutating the ubiquitination site K376 of RIPK1 (K376R) in mice activates cell death resulting in embryonic lethality. In contrast to\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K376R\/K376R<\/jats:italic>\n                    <\/jats:sup>\n                    mice,\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K115R\/K115R<\/jats:italic>\n                    <\/jats:sup>\n                    mice reached adulthood and showed slightly higher responsiveness to TNF-induced death. Cell death observed in\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K376R\/K376R<\/jats:italic>\n                    <\/jats:sup>\n                    embryos relied on RIPK1 kinase activity as administration of RIPK1 inhibitor GNE684 to pregnant heterozygous mice effectively blocked cell death and prolonged survival. Embryonic lethality of\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K376R\/K376R<\/jats:italic>\n                    <\/jats:sup>\n                    mice was prevented by the loss of TNFR1, or by simultaneous deletion of caspase-8 and RIPK3. Interestingly, elimination of the wild-type allele from adult\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K376R\/cko<\/jats:italic>\n                    <\/jats:sup>\n                    mice was tolerated. However, adult\n                    <jats:italic>Ripk1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>K376R\/cko<\/jats:italic>\n                    <\/jats:sup>\n                    mice were exquisitely sensitive to TNF-induced hypothermia and associated lethality. Absence of the K376 ubiquitination site diminished K11-linked, K63-linked, and linear ubiquitination of RIPK1, and promoted the assembly of death-inducing cellular complexes, suggesting that multiple ubiquitin linkages contribute to the stability of the RIPK1 signaling complex that stimulates NF-\u03baB and MAPK activation. In contrast, mutating K115 did not affect RIPK1 ubiquitination or TNF stimulated NF-\u03baB and MAPK signaling. Overall, our data indicate that selective impairment of RIPK1 ubiquitination can lower the threshold for RIPK1 activation by TNF resulting in cell death and embryonic lethality.\n                  <\/jats:p>","DOI":"10.1038\/s41418-020-00629-3","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T05:03:24Z","timestamp":1601442204000},"page":"985-1000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death"],"prefix":"10.1038","volume":"28","author":[{"given":"Matthias","family":"Kist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3 G.","family":"K\u0151m\u0171ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Goncharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Dugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merone","family":"Roose-Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domagoj","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"629_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tcb.2015.01.001","volume":"25","author":"K Newton","year":"2015","unstructured":"Newton K. RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol. 2015;25:347\u201353.","journal-title":"Trends Cell Biol"},{"key":"629_CR2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689\u201397.","journal-title":"Nat Immunol"},{"key":"629_CR3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/JLB.2MR0120-510R","volume":"107","author":"KN Atretkhany","year":"2020","unstructured":"Atretkhany KN, Gogoleva VS, Drutskaya MS, Nedospasov SA. Distinct modes of TNF signaling through its two receptors in health and disease. J Leukoc Biol. 2020;107:893\u2013905.","journal-title":"J Leukoc Biol."},{"key":"629_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09690-0","volume":"10","author":"Y Dondelinger","year":"2019","unstructured":"Dondelinger Y, Delanghe T, Priem D, Wynosky-Dolfi MA, Sorobetea D, Rojas-Rivera D, et al. Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat Commun. 2019;10:1729.","journal-title":"Nat Commun."},{"key":"629_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00406-w","volume":"8","author":"J Geng","year":"2017","unstructured":"Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun. 2017;8:359.","journal-title":"Nat Commun."},{"key":"629_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"629_CR7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313\u201321.","journal-title":"Nat Chem Biol"},{"key":"629_CR8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","volume":"574","author":"K Newton","year":"2019","unstructured":"Newton K, Wickliffe KE, Dugger DL, Maltzman A, Roose-Girma M, Dohse M, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature. 2019;574:428\u201331.","journal-title":"Nature."},{"key":"629_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui N, Boyden SE, Oda H, Wood GM, Stone DL, Chau D, et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature. 2020;577:103\u20138.","journal-title":"Nature."},{"key":"629_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","volume":"577","author":"P Tao","year":"2019","unstructured":"Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature. 2019;577:109\u201314.","journal-title":"Nature."},{"key":"629_CR11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/cdd.2017.33","volume":"24","author":"A Witt","year":"2017","unstructured":"Witt A, Vucic D. Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling. Cell Death Differ. 2017;24:1160\u201371.","journal-title":"Cell Death Differ"},{"key":"629_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"CK Ea","year":"2006","unstructured":"Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006;22:245\u201357.","journal-title":"Mol Cell"},{"key":"629_CR13","doi-asserted-by":"crossref","first-page":"13636","DOI":"10.1074\/jbc.M600620200","volume":"281","author":"H Li","year":"2006","unstructured":"Li H, Kobayashi M, Blonska M, You Y, Lin X. Ubiquitination of RIP is required for tumor necrosis factor \u03b1-induced NF-\u03baB activation. J Biol Chem. 2006;281:13636\u201343.","journal-title":"J Biol Chem"},{"key":"629_CR14","doi-asserted-by":"crossref","first-page":"13636","DOI":"10.1074\/jbc.M600620200","volume":"281","author":"H Li","year":"2006","unstructured":"Li H, Kobayashi M, Blonska M, You Y, Lin X. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem. 2006;281:13636\u201343.","journal-title":"J Biol Chem"},{"key":"629_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cdd.2016.78","volume":"24","author":"MC de Almagro","year":"2017","unstructured":"de Almagro MC, Goncharov T, Izrael-Tomasevic A, Duttler S, Kist M, Varfolomeev E, et al. Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death. Cell Death Differ. 2017;24:26\u201337.","journal-title":"Cell Death Differ"},{"key":"629_CR16","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1806973115","volume":"115","author":"P Amin","year":"2018","unstructured":"Amin P, Florez M, Najafov A, Pan H, Geng J, Ofengeim D, et al. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFalpha-mediated apoptosis. Proc Natl Acad Sci USA. 2018;115:E5944\u2013E53.","journal-title":"Proc Natl Acad Sci USA"},{"key":"629_CR17","doi-asserted-by":"crossref","first-page":"11944","DOI":"10.1073\/pnas.1715742114","volume":"114","author":"H Wang","year":"2017","unstructured":"Wang H, Meng H, Li X, Zhu K, Dong K, Mookhtiar AK, et al. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP. Proc Natl Acad Sci USA. 2017;114:11944\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"629_CR18","doi-asserted-by":"crossref","first-page":"24295","DOI":"10.1074\/jbc.C800128200","volume":"283","author":"E Varfolomeev","year":"2008","unstructured":"Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNF\u03b1)-induced NF-\u03baB activation. J Biol Chem. 2008;283:24295\u20139.","journal-title":"J Biol Chem"},{"key":"629_CR19","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/emboj.2010.300","volume":"29","author":"JN Dynek","year":"2010","unstructured":"Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. Embo J. 2010;29:4198\u2013209.","journal-title":"Embo J"},{"key":"629_CR20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","volume":"30","author":"MJ Bertrand","year":"2008","unstructured":"Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008;30:689\u2013700.","journal-title":"Mol Cell."},{"key":"629_CR21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","volume":"69","author":"A Annibaldi","year":"2018","unstructured":"Annibaldi A, Wicky John S, Vanden Berghe T, Swatek KN, Ruan J, Liccardi G, et al. Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2. Mol Cell. 2018;69:566\u201380 e5.","journal-title":"Mol Cell"},{"key":"629_CR22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell. 2009;36:831\u201344.","journal-title":"Mol Cell."},{"key":"629_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12550","volume":"277","author":"V Kondylis","year":"2017","unstructured":"Kondylis V, Kumari S, Vlantis K, Pasparakis M. The interplay of IKK, NF-kappaB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation. Immunol Rev. 2017;277:113\u201327.","journal-title":"Immunol Rev."},{"key":"629_CR24","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1101\/gad.1360605","volume":"19","author":"JH Shim","year":"2005","unstructured":"Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005;19:2668\u201381.","journal-title":"Genes Dev"},{"key":"629_CR25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","volume":"26","author":"G Sabio","year":"2014","unstructured":"Sabio G, Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol. 2014;26:237\u201345.","journal-title":"Semin Immunol"},{"key":"629_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.12688\/f1000research.17023.1","volume":"8","author":"J Holbrook","year":"2019","unstructured":"Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott M. Tumour necrosis factor signalling in health and disease. F1000Res. 2019;8:111.","journal-title":"F1000Res"},{"key":"629_CR27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang JG, Alvarez-Diaz S, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39:443\u201353.","journal-title":"Immunity."},{"key":"629_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell."},{"key":"629_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang H, Sun L, Su L, Rizo J, Liu L, Wang L-F, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133\u201346.","journal-title":"Mol Cell"},{"key":"629_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15:135\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"629_CR31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","volume":"27","author":"S Patel","year":"2020","unstructured":"Patel S, Webster JD, Varfolomeev E, Kwon YC, Cheng JH, Zhang J, et al. RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ. 2020;27:161\u201375.","journal-title":"Cell Death Differ"},{"key":"629_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20:19\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"629_CR33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science. 2014;343:1357\u201360.","journal-title":"Science"},{"key":"629_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","volume":"41","author":"S Martens","year":"2020","unstructured":"Martens S, Hofmans S, Declercq W, Augustyns K, Vandenabeele P. Inhibitors targeting RIPK1\/RIPK3: old and new drugs. Trends Pharm Sci. 2020;41:209\u201324.","journal-title":"Trends Pharm Sci"},{"key":"629_CR35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","volume":"160","author":"JJ Peschon","year":"1998","unstructured":"Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol. 1998;160:943\u201352.","journal-title":"J Immunol"},{"key":"629_CR36","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1093\/nar\/gng012","volume":"31","author":"J Seibler","year":"2003","unstructured":"Seibler J, Zevnik B, Kuter-Luks B, Andreas S, Kern H, Hennek T, et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003;31:e12.","journal-title":"Nucleic Acids Res"},{"key":"629_CR37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339:819\u201323.","journal-title":"Science"},{"key":"629_CR38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823\u20136.","journal-title":"Science."},{"key":"629_CR39","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1073\/pnas.82.18.6060","volume":"82","author":"D Pennica","year":"1985","unstructured":"Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:6060\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"629_CR40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-\u03baB activation, and TNF\u03b1-dependent apoptosis. Cell. 2007;131:669\u201381.","journal-title":"Cell."},{"key":"629_CR41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.158","volume":"6","author":"MC de Almagro","year":"2015","unstructured":"de Almagro MC, Goncharov T, Newton K, Vucic D. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis. 2015;6:e1800.","journal-title":"Cell Death Dis"},{"key":"629_CR42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011;471:368\u201372.","journal-title":"Nature"},{"key":"629_CR43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature. 2011;471:363\u20137.","journal-title":"Nature."},{"key":"629_CR44","volume":"10","author":"Y Tang","year":"2019","unstructured":"Tang Y, Tu H, Zhang J, Zhao X, Wang Y, Qin J, et al. K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation. Nat Commun. 2019;10:4157.","journal-title":"Nat Commun."},{"key":"629_CR45","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang H, Xu C, Li X, Li M, Wu X, et al. Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis. Nat Commun. 2019;10:4158.","journal-title":"Nat Commun."},{"key":"629_CR46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2019.03.006","volume":"40","author":"N Peltzer","year":"2019","unstructured":"Peltzer N, Walczak H. Cell death and inflammation \u2013 a vital but dangerous liaison. Trends Immunol. 2019;40:387\u2013402.","journal-title":"Trends Immunol"},{"key":"629_CR47","doi-asserted-by":"crossref","first-page":"eaax8295","DOI":"10.1126\/scisignal.aax8295","volume":"13","author":"S Jensen","year":"2020","unstructured":"Jensen S, Seidelin JB, LaCasse EC, Nielsen OH. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. Sci Signal. 2020;13:eaax8295.","journal-title":"Sci Signal"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00629-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T14:48:42Z","timestamp":1696776522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1038\/s41418-020-00629-3","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}